CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen
about
CYP2D6*3 (A2549del), *4 (G1846A), *10 (C100T) and *17 (C1023T) genetic polymorphisms in Iranian breast cancer patients treated with adjuvant tamoxifen
description
scientific article published on 07 September 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
CYP2D6*3 (A2549del), *4 (G1846 ...... reated with adjuvant tamoxifen
@en
CYP2D6*3 (A2549del), *4 (G1846 ...... reated with adjuvant tamoxifen
@nl
type
label
CYP2D6*3 (A2549del), *4 (G1846 ...... reated with adjuvant tamoxifen
@en
CYP2D6*3 (A2549del), *4 (G1846 ...... reated with adjuvant tamoxifen
@nl
prefLabel
CYP2D6*3 (A2549del), *4 (G1846 ...... reated with adjuvant tamoxifen
@en
CYP2D6*3 (A2549del), *4 (G1846 ...... reated with adjuvant tamoxifen
@nl
P2093
P2860
P356
P1433
P1476
CYP2D6*3 (A2549del), *4 (G1846 ...... reated with adjuvant tamoxifen
@en
P2093
Akbar Hedayatizadeh-Omran
Ebrahim Salehifar
Ehsan Zaboli
Ghasem Janbabai
Omolbanin Amjadi
Siavash Moradi
P2860
P304
P356
10.3892/BR.2018.1145
P407
P577
2018-09-07T00:00:00Z